The Foundation for Vaccine Research - Working to Secure Our Children's Future
Photo: Clive Gray, Cape Town

If a Job’s worth doing,
it’s worth doing well

Our website is being redesigned to improve performance and readability on all devices. It will relaunch shortly.

Latest News

23 July 2015

Call for establishing a global vaccine development fund published in the New England Journal of Medicine.

Plotkin SA, Mahmoud AAF, Farrar J. Establishing a global vaccine development fund. N Engl J Med. 2015 Jul 23;373(4):297-300

See updated list of diseases and infections uncontrolled by vaccination.
 

Supplement to the N Engl J Med article

Audio interview with Dr. Stanley Plotkin, Emeritus Professor, University of Pennsylvania, and a Director, Foundation for Vaccine Research, on a strategy for stimulating and supporting global vaccine research. (9:21)

Listen
Download

close

Vaccine-Preventable Diseases and Infections and Targets Currently Uncontrolled by Vaccination. Updated August 21, 2015.*

Diseases and infections with commonly used vaccines

  • Diphtheria
  • Haemophilus influenzae type b
  • Hepatitis type A
  • Hepatitis type B
  • Human papillomavirus (HPV)
  • Influenza types A and B (seasonal)
  • Japanese encephalitis
  • Measles
  • Meningococcus
  • Mumps
  • Pertussis (whooping cough)
  • Polio
  • Pneumoccocus
  • Rabies
  • Rotavirus
  • Rubella
  • Smallpox
  • Tetanus
  • Tickborne encephalitis
  • Typhoid
  • Varicella (chickenpox)
  • Yellow fever

Diseases and infections with limited-use vaccines

  • Adenovirus types 4 and 7
  • Anthrax

Diseases and infections with no vaccines or only partially effective vaccines

  • Campylobacter
  • Cancer
  • Candida
  • Chikungunya
  • Chlamydia Moraxella
  • Clostridium difficile
  • Cryptosporidium
  • Cytomegalovirus
  • Dengue
  • Ebola and viral hemorrhagic fevers
  • Enterovirus including EV71, EV68, CA16
  • Epstein-Barr virus
  • Escherichia coli
  • Haemophilus influenzae, nontypable
  • Helicobacter
  • Helminths (numerous)
  • Hendra virus
  • Hepatitis type C
  • Hepatitis type E
  • Herpesvirus type 6
  • Herpes simplex
  • HIV/AIDS
  • Influenza, universal
  • Influenza, avian types H5 and H7
  • Leishmaniasis
  • Lyme disease
  • Malaria
  • MERS
  • Metapneumovirus
  • Moraxella (for otitis)
  • Neisseria gonorrhoeae
  • Nipah virus
  • Norovirus
  • Nosocomial bacteria
  • Parainfluenza
  • Plague
  • Rhinovirus
  • RSV
  • Salmonella paratyphi
  • SARS
  • Schistosomiasis
  • Shigella
  • Staphylococcus
  • Strep Group A
  • Strep Group B
  • Toxoplasmosis
  • Trypanosomiasis
  • Tuberculosis
  • West Nile virus

* Updated information is from the Foundation for Vaccine Research. Nipah and Hendra viruses were unintentionally omitted in the list published in NEJM. MERS denotes Middle East Respiratory Syndrome, RSV Respiratory Syncytial Virus, and SARS Severe Acute Respiratory Syndrome. Vaccines for some of the targets indicated above are in advanced development, but most are not.

News Update

21 August 2015

Support builds for reform of vaccine development through proposed fund.

See editorial in The New York Times; see articles in The New York Times, Wall Street Journal, Reuters, Business Insider, CIDRAP News, and Fierce Vaccines

 

Global Dispatches Podcast

Interview with Dr. Jeremy Farrar, Professor of Tropical Medicine and Director of the Welcome Trust, in which he discusses the implications of the recent Ebola vaccine trial and how the creation of a global vaccine development fund will spur the development and deployment of vaccines to counter fast emerging epidemics. (12:00)

Listen
Download